Director/PDMR Shareholding

RNS Number : 2466P
GlaxoSmithKline PLC
16 February 2016
 

GlaxoSmithKline plc

 

Notification of Transactions of Directors and Persons Discharging Managerial   Responsibility

 

GlaxoSmithKline Performance Share Plan

Sale of shares to meet tax liabilities

 

 

The table below sets out changes in the interests of Directors and Persons Discharging Managerial Responsibilities ('PDMR') in the Ordinary Shares of GlaxoSmithKline plc arising from the sale of Ordinary Shares at a fair market value price of £14.06 per Ordinary Share on 12 February 2016 to meet tax liabilities following the vesting of awards granted in 2012 under the GlaxoSmithKline 2009 Performance Share Plan ('PSP').

 

Director/PDMR

Number of Ordinary Shares sold to meet tax liabilities following the vesting of a PSP award

Sir Andrew Witty*

68,158

Mr S Dingemans*

39,987

Mr R Connor

17,134

Mr A Hussain

24,104

Mr D Redfern

13,136

Ms C Thomas

18,562

Mr P Thomson

8,853

Dr P Vallance

39,979

Ms E Walmsley

22,845

Mrs VA Whyte**

2,451

 

* Denotes an Executive Director

** Sale for tax of vested PSP awards granted under the non CET Performance Share Plan

 

The table below sets out changes in the interests of PDMRs in the American Depositary Shares ('ADS') of GlaxoSmithKline plc arising from the withholding of ADSs at a closing share price of $39.15 per ADS on 12 February 2016 to establish the fair market value to meet tax liabilities following the vesting of awards granted in 2012 under the PSP.

 

Director/PDMR

Number of ADSs withheld to meet tax liabilities following the vesting of a PSP award

Dr M Slaoui*          

26,557

Mr N Hirons**

1,390

Mr D Troy

16,364

 

* Denotes an Executive Director

** Sale for tax of vested PSP awards granted under the non CET Performance Share Plan

The Company, Directors and PDMRs were advised of these transactions on 16 February 2016.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

V A Whyte

Company Secretary

 

 

16 February 2016


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQQLFFQLFFBBL

Companies

GSK (GSK)
UK 100

Latest directors dealings